Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025

Rhea-AI Summary

Xtant Medical (NYSE American: XTNT) will release its third-quarter 2025 financial results for the period ended September 30, 2025 before market open on Tuesday, November 11, 2025. Sean Browne, President and CEO, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET the same day.

Conference dial-in details: 888-506-0062 (U.S.), international 973-528-0011, passcode 579614. A live webcast will be available at https://www.webcaster5.com/Webcast/Page/3039/52972, and a replay will be posted under Investor Info at https://xtantmedical.com/.

BELGRADE, Mont., Nov. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the third quarter ended September 30, 2025, before the start of trading on Tuesday, November 11, 2025.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial officer, will host a conference call at 8:30am ET on that day.

Conference Details:

Conference Date: Tuesday, November 11, 2025
Conference Time: 8:30 AM ET
Conference Dial-in: 888-506-0062
International Dial-in: 973-528-0011
Passcode: 579614
Conference Call Name: Xtant Medical Q3 2025 Financial Results
Webcast link: https://www.webcaster5.com/Webcast/Page/3039/52972

Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-third-quarter-2025-financial-results-on-november-11-2025-302603814.html

SOURCE Xtant Medical Holdings, Inc.

FAQ

When will Xtant Medical (XTNT) report Q3 2025 results?

Xtant Medical will release Q3 2025 results before trading on Tuesday, November 11, 2025.

What time is the Xtant Medical (XTNT) Q3 2025 conference call?

The company will host a conference call on November 11, 2025 at 8:30 AM ET.

How can investors join the Xtant Medical (XTNT) Q3 2025 call?

Dial 888-506-0062 (U.S.) or 973-528-0011 (international) and use passcode 579614.

Where is the Xtant Medical (XTNT) Q3 2025 webcast?

The live webcast is at https://www.webcaster5.com/Webcast/Page/3039/52972.

Will a replay of the Xtant Medical (XTNT) Q3 2025 call be available?

Yes. A replay will be posted under Investor info at https://xtantmedical.com/ after the live call.